Music industry professionals represent a vulnerable population to music induced hearing disorders (MIHDs). In addition to the impacts that the development of hearing disorders secondary to noise exposure can have on quality of life and communication, MIHDs can impact the afflicted individual's professional performance, and in turn employability. Within the music industry there are individual and institutional barriers to traditional hearing conservation interventions. Pharmaceutical interventions for hearing loss could potentially address some of these barriers, yet there are significant considerations and cautions which should be addressed.